9999999997-12-013039.txt : 20120829 9999999997-12-013039.hdr.sgml : 20120829 20120829130426 ACCESSION NUMBER: 9999999997-12-013039 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120829 DATE AS OF CHANGE: 20120829 20120829 20120829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 121062415 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(()-CV`8G/\QF8&!EV@F09&-&)_XRS_@`$&`#630?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``(>3@94P,@` MDN5H0!9C@6(&AAL,W`RR"BC"(``08`!1X%_@T* M96YD7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I;ORH9,4*X M(3/X].N$\T!2VA1C80V^5*DN%MY]G'O7.MFK@QN)B\IH4]KR0`Q)NF3E"OMG M;`\Y_=KV:^\/.8ZHC'Q(JF\`^E-%A&#XU/#4?7-TQ,.?0-RYSN"JAA=(P2WI M(3TNX4MWP2&K)PC$($+UG10C`AY`UG,P3B>D]YG!AIL#FTK1+WU3C6N"&IAU M]B[?Z`$Z.J0QP@GB2$3`C40(20=F',CZ$1D#QB>?+[IO*J(\IKV6GA5?:D\)ZKN>)_UES% M!OD$10$?MZ.KG*BS)3?,IJOA`;.;"KYWI^)[X.\% M?$&:^[Q8<562!C%!I>U5,:AC)$#QO1+^'A_ZI3A><4_&BJMZTXL+N47`Y?R6X7A%>"6YJS]#;B(%)8.M)&`-O.Z6W2LM]O>6O]59%1S0& M;-3_?6.$FCV.Y6/[D^/UO>P=DE0`?/N/Y?88O-P>AY/;WP(,`+D'?&0-"F5N M9'-TRW//T5?I MX/)W]O;MY=WX=L(\]N[=U63,!I?C!X\M7V"!O2R+P66:>DRR]--`*N9ZL`Q_ M?2]BL3<42<32SGU!+[8`W>EDX[@,[U^X'^F[P<>*O%0/A;)$+]69^Y6YFZZ M4I&<_H"[92#BJ'DYW!0YU]P-G?&'^UON^DZ*$_JB93K`1M,)H^D?7'K.^&?N M!LYH^A.O9-GX-URYX^X0!J7%29(&FM*)Z9$SIUWPC0O2$W%6%M(SEAD+*/B^DY2,W$E'<=..&2ZD- M)/O0`S8%V)2"Z>+P/(DJ0^$9UG%Q[@G?K^92A<,`U_3E>M^OS],JP4@:&$G, MUSUP_J8[:FG%MT531(N!(Y7SE2D':E;-;P;,=0P1>3AGP/J^96 M_,M0^KG2L&$VUT!XOA;#E6R!PPX3S-#G'9YF>!>[XNK+)I)I!9+F=J;!(*.JKUJ-HM%%'226=@H93C: M1V:VU:8_5D=L;5WQF/!*IFA@`V`IM0A77-E:V-E#!1E]C'/Q1U2.*ZI(\ZFQ3^`:.>M(,N)I1JL&4$JEX@TUW4UH?-BOI,[R>M,,\( M)X^5T01/^CA1=N#B<=T=>3,C:BF)CS:&/3!%N)R9=!"OL)*8IJK/JIL6Q%)+G-J=0>4!AMK#5[X1TW8&^%$7B:$(BTG:S\1(:@)P"]&7*PCQQ< M&=9QWXAK+J7%"WA;?H`%04\(`4T0U`@6ANJC`QH6'SF,]!G0YT7+Q`FO5/]# M(P'97*6-'",ODT%;&EL6H9>-2)):M)`N6=/4%A);/1IQ$[6ZD12ZS.JH%*7F M`!I+MMTO#OM)7O4_'PIJ5=N_-"DL=>&1(76K$LP&D9"#1FAI;3M14&ZJT(.@ MH8(OUB]2O5]5QN*J%NY)'&[C;H6`1B)(,*\>3N!0^K?#1<:*6&V6BT(%=' MQ98KVQHTZ&BM"+-T(^&6T2<=J@I5JKJ"R:@W^KF;B+"S0<3-1[O7^VB7PU:' M:!U)SC61\Y,9_"B1%:36Y,,B@_:LT:X?/OCF0HE`)`O8TYPTRUU MK=7:'[(&Y\U6&U*KC>E@3QR5UXQC*XR]`3BCM?YQD?1E1JGSO1L9J84]S6-U MFZCYHDEZ%P==6K\AM?SW9\JEZ0H74#_/!O#[N7U'F$(S]2_U*ZK95XF&JDQV(TI;8SOQT\)PWINI?62R2N#-!?N-]E<2].0IZJT>%_4?. MOM+^^X0X-#!/W.#@5]4=/I`SC.9RC6UU_ICCA#W08V2^PE^387'LTQK=)B>M['`H<7M![\/C8O:`;&,.F>\%I M9%RG@W\%&`!X;+"-#0IE;F1S=')E86T-96YD;V)J#30W(#`@;V)J#3P\+T9I M;'1E+V!-+B@J`=('@-@H);4X&4A_`>+,\I("H#AC`I`M MDI0-9H/4B62'!#D#V1U`-E]):@5(C,$YOZ"R*#,]HT3!T-+24L$Q)3\I52&X MLK@D-;=8P3,O.;^H(+\HL20U!:@6:@<(\+L7)58JN"?FYB8J&.D9D>AR(@`H M+"&LSR'@,&(4.X\00X#DTJ(R*).1R9B!`2#``$G&."\-"F5N9'-T7!E+T]B:E-T;3X^55%!%22B1%(EJ$J[(%Q19R'NJYA53%1%"54($2AX1*05$2:E"5%07 M"``$45-=5L0%U37"@P<,,S(FFL%%JHD##D`/1V3TQ"4R,2TGXC!.R!"(:V05 M,1Y&*$H2\`2G"'A28FSPI,;@X`4T"7BA]"3@A9II'FC^&@$OQD`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`Q(#8S+C$S.30S.2P@ M,C`Q,"\P.2\R-RTQ,SHS-SHR-B`@("`@("`@(CX*("`@/')D9CI21$8@>&UL M;G,Z&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA M<"\Q+C`O(CX*("`@("`@("`@/'AM<#I-;V1I9GE$871E/C(P,3(M,#@M,CE4 M,3,Z,#,M,#0Z,#`\+WAM<#I-;V1I9GE$871E/@H@("`@("`@("`\>&UP.D-R M96%T941A=&4^,C`Q,BTP."TR.50Q,SHP,CHU-BTP-#HP,#PO>&UP.D-R96%T M941A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$871E/C(P,3(M,#@M,CE4 M,3,Z,#,M,#0Z,#`\+WAM<#I-971A9&%T841A=&4^"B`@("`@("`@(#QX;7`Z M0W)E871O&UP34TZ26YS=&%N8V5)1#YU=6ED.F8P9C,Q.#-D+31C.3,M M-&%C."UB,C`X+3`P9#4U8S4P,&%B-CPO>&UP34TZ26YS=&%N8V5)1#X*("`@ M("`@("`@/'AM<$U-.G-U8FIE8W0^"B`@("`@("`@("`@(#QR9&8Z4V5Q/@H@ M("`@("`@("`@("`@("`\#I3 M;W5R8V5-;V1I9FEE9#X*("`@("`@("`@/'!D9G@Z0V]M<&%N>3Y396-U&AA;F=E($-O;6UI3X*("`@ M("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO7!E+T]B:E-T M;3X^K(@>/"<-EL;I%W9 M)J!O;PHB@K>!&3YFI@!ANTTR[QJ6R/=QLN?VH;M7=*'*BW66>M"=@<.ST=V- M(-2M[7O+79@*:1=2KAU%^29%E>(J7:LIIO/%&&FB%_H+&Q\14$R7-+@P,F6HN4U4!@G%_9247!L;